Low barrier buprenorphine treatment for persons experiencing homelessness and injecting heroin in San Francisco
Abstract Background Opioid overdose is a leading cause of death in persons experiencing homelessness (PEH), despite effective medications for opioid use disorder (OUD). In 2016, the San Francisco Street Medicine Team piloted a low barrier buprenorphine program with the primary goal of engaging and r...
Main Authors: | Jamie Carter, Barry Zevin, Paula J. Lum |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-05-01
|
Series: | Addiction Science & Clinical Practice |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13722-019-0149-1 |
Similar Items
-
Predisposing, enabling and need factors of heroin addicts’ using prescribed methadone or buprenorphine for a year or longer: An exploratory study of drug treatment for heroin addicts in the Swedish welfare system
by: Nilsson Marcus Blom, et al.
Published: (2014-04-01) -
Buprenorphine Induction Using Microdosing for the Management of Opioid Use Disorder in Pregnancy
by: Neil B. Patel, et al.
Published: (2024-01-01) -
Adapting low-dose buprenorphine induction to meet patient needs: A pilot study
by: Zoe A. Karavolis, et al.
Published: (2022-12-01) -
Patients' perspectives on buprenorphine subcutaneous implant: a case series
by: Claudio Pierlorenzi, et al.
Published: (2024-04-01) -
A qualitative examination of the current management of opioid use disorder and barriers to prescribing buprenorphine in a Canadian emergency department
by: David Wiercigroch, et al.
Published: (2021-04-01)